抗真菌药在特殊人群的应用

doi:10.35541/cjd.20200035

Abstract

Abstract: 【Abstract】 Antifungal agents have shown good efficacy and tolerability in the general population. However, there are great challenges in antifungal treatments among some special populations due to their special conditions, such as children, the elderly, pregnant women and patients with hepatic insufficiency. This review summarizes recommendations for the use of common antifungal agents in the above special populations.

Key words: Antifungal agents, Child, Aged, Pregnant women, Hepatic insufficiency, No-observed-adverse-effect level

Kong Xue, Shi Dongmei, Liu Weida. Application of antifungal agents in special populations[J]. Chinese Journal of Dermatology, 2022, 55(1): 80-83.doi:10.35541/cjd.20200035

References ［41］

［1］	Kaushik N, Pujalte GG, Reese ST. Superficial fungal infections［J］. Prim Care Clin Office Pract, 2015,42（4）:501⁃516. doi:10. 1016/j.pop.2015.08.004.
［2］	中国体癣和股癣诊疗指南工作组. 中国体癣和股癣诊疗指南（2018修订版）［J］. 中国真菌学杂志, 2019,14（1）:1⁃3.
［3］	Hawkins DM, Smidt AC. Superficial fungal infections in children［J］. Pediatr Clin N Am, 2014,61（2）:443⁃455. doi:10.1016/j.pcl. 2013.12.003.
［4］	Gupta AK, Mays RR, Versteeg SG, et al. Onychomycosis in children: safety and efficacy of antifungal agents［J］. Pediatr Dermatol, 2018,35（5）:552⁃559. doi: 10.1111/pde.13561.
［5］	Ameen M, Lear JT, Madan V, et al. British Association of Dermatologists′ guidelines for the management of onychomycosis 2014［J］. Br J Dermatol, 2014,171（5）:937⁃958. doi: 10.1111/bjd.13358.
［6］	Chen X, Jiang X, Yang M, et al. Systemic antifungal therapy for tinea capitis in children: an abridged Cochrane review［J］. J Am Acad Dermatol, 2017,76（2）:368⁃374. doi: 10.1016/j.jaad. 2016.08.061.
［7］	中国头癣诊疗指南工作组. 中国头癣诊断和治疗指南（2018修订版）［J］. 中国真菌学杂志, 2019,14（1）:4⁃6.
［8］	中华医学会皮肤性病学分会, 中国中西医结合学会皮肤性病专业委员会, 中国医师协会皮肤科医师分会. 中国甲真菌病诊疗指南（2015年版）［J］. 中国真菌学杂志, 2019,10（2）:118⁃125. doi: 10.3969/j.issn.1673⁃3827.2015.02.018.
［9］	Kaul S, Yadav S, Dogra S. Treatment of dermatophytosis in elderly, children, and pregnant women［J］. Indian Dermatol Online J, 2017,8（5）:310⁃318. doi: 10.4103/idoj.IDOJ_169_17.
［10］	Gupta AK, Foley KA. Antifungal treatment for pityriasis versicolor［J］. J Fungi （Basel）, 2015,1（1）:13⁃29. doi: 10.3390/jof1010013.
［11］	Ramírez SMC. Sporotrichosis: the story of an endemic region in Peru over 28 years （1985 to 2012）［J/OL］. PLoS One, 2015,10（6）:e0127924. doi: 10.1371/journal.pone.0127924.
［12］	Song Y, Li SS, Zhong SX, et al. Report of 457 sporotrichosis cases from Jilin province, northeast China, a serious endemic region［J］. J Eur Acad Dermatol Venereol, 2013,27（3）:313⁃318. doi: 10.1111/j.1468⁃3083.2011.04389.x.
［13］	中华医学会皮肤性病学分会真菌学组, 中国医师协会皮肤科医师分会医学真菌亚专业委员会, 中西医结合学会皮肤性病专业委员会真菌学组.孢子丝菌病诊疗指南［J］. 中华皮肤科杂志, 2016,49（7）:456⁃459. doi:10.3760/cma.j.issn.0412⁃4030. 2016.07.002.
［14］	Kauffman CA, Bustamante B, Chapman SW, et al. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America［J］. Clin Infect Dis, 2007,45（10）:1255⁃1265. doi: 10.1086/522765.
［15］	Groll AH, Tragiannidis A. Recent advances in antifungal prevention and treatment［J］. Semin Hematol, 2009,46（3）:212⁃229. doi: 10.1053/j.seminhematol.2009.03.003.
［16］	Hani U, Shivakumar HG, Vaghela R, et al. Candidiasis: a fungal infection⁃⁃current challenges and progress in prevention and treatment［J］. Infect Disord Drug Targets, 2015,15（1）:42⁃52. doi: 10.2174/1871526515666150320162036.
［17］	Puia⁃Dumitrescu M, Smith PB. Antifungal drugs in newborns and children［J］. Pediatr Clin North Am, 2017,64（6）:1389⁃1402. doi: 10.1016/j.pcl.2017.08.013.
［18］	Tragiannidis A, Tsoulas C, Groll AH. Invasive candidiasis and candidaemia in neonates and children: update on current guidelines［J］. Mycoses, 2015,58（1）:10⁃21. doi: 10.1111/myc. 12268.
［19］	Mantadakis E, Pana ZD, Zaoutis T. Candidemia in children: Epidemiology, prevention and management［J］. Mycoses, 2018,61（9）:614⁃622. doi: 10.1111/myc.12792.
［20］	Loo DS. Onychomycosis in the elderly : drug treatment options［J］. Drugs Aging, 2007,24（4）:293⁃302. doi: 10.2165/00002512⁃200724040⁃00003.
［21］	Gupta AK, Lane D, Paquet M. Systematic review of systemic treatments for tinea versicolor and evidence⁃based dosing regimen recommendations［J］. J Cutan Med Surg, 2014,18（2）:79⁃90. doi: 10.2310/7750.2013.13062.
［22］	Macedo PM, Lopes⁃Bezerra LM, Bernardes⁃Engemann AR, et al. New posology of potassium iodide for the treatment of cutaneous sporotrichosis: study of efficacy and safety in 102 patients［J］. J Eur Acad Dermatol Venereol, 2015,29（4）:719⁃724. doi: 10.1111/ jdv.12667.
［23］	Orofino⁃Costa R, Macedo PM, Rodrigues AM, et al. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics［J］. An Bras Dermatol, 2017,92（5）:606⁃620. doi: 10.1590/abd1806⁃4841.2017279.
［24］	Pappas PG, Kauffman CA, Andes DR, et al. Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America［J］. Clin Infect Dis, 2016,62（4）:409⁃417. doi: 10.1093/cid/civ1194.
［25］	Cuenca⁃Estrella M, Verweij PE, Arendrup MC, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures［J］. Clin Microbiol Infect, 2012,18 Suppl 7:9⁃18. doi: 10.1111/1469⁃0691.12038.
［26］	Brüggemann RJ, Alffenaar JW, Blijlevens NM, et al. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents［J］. Clin Infect Dis, 2009,48（10）:1441⁃1458. doi: 10.1086/598327.
［27］	Macedo PM, Lopes⁃Bezerra LM, Bernardes⁃Engemann AR, et al. New posology of potassium iodide for the treatment of cutaneous sporotrichosis: study of efficacy and safety in 102 patients［J］. J Eur Acad Dermatol Venereol, 2015,29（4）:719⁃724. doi: 10.1111/ jdv.12667.
［28］	Stockton DL, Paller AS. Drug administration to the pregnant or lactating woman: a reference guide for dermatologists［J］. J Am Acad Dermatol, 1990,23（1）:87⁃103. doi: 10.1016/0190⁃9622（90）70192⁃k.
［29］	Patel VM, Schwartz RA, Lambert WC. Topical antiviral and antifungal medications in pregnancy: a review of safety profiles［J］. J Eur Acad Dermatol Venereol, 2017,31（9）:1440⁃1446. doi: 10.1111/jdv.14297.
［30］	Pilmis B, Jullien V, Sobel J, et al. Antifungal drugs during pregnancy: an updated review［J］. J Antimicrob Chemother, 2015,70（1）:14⁃22. doi: 10.1093/jac/dku355.
［31］	Cottreau JM, Barr VO. A review of antiviral and antifungal use and safety during pregnancy［J］. Pharmacotherapy, 2016,36（6）:668⁃678. doi: 10.1002/phar.1764.
［32］	Workowski KA. Centers for disease control and prevention sexually transmitted diseases treatment guidelines［J］. Clin Infect Dis, 2015,61 *（Suppl 8）:S759⁃S762. doi: 10.1093/cid/civ771.
［33］	Howley MM, Carter TC, Browne ML, et al. Fluconazole use and birth defects in the national birth defects prevention study［J］. Am J Obstet Gynecol, 2016,214（5）:657.e1⁃9. doi: 10.1016/j.ajog. 2015.11.022.
［34］	Barros MB, Schubach Ade O, do Valle AC, et al. Cat⁃transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis, 2004,38（4）:529⁃535. doi: 10. 1086/381200.
［35］	Fichman V, ACFD V, de Macedo PM, et al. Cryosurgery for the treatment of cutaneous sporotrichosis in four pregnant women［J/OL］. PLoS Negl Trop Dis, 2018,12（4）:e0006434. doi: 10.1371/journal.pntd.0006434.
［36］	Mahajan VK. Sporotrichosis: an overview and therapeutic options［J］. Dermatol Res Pract, 2014,2014:272376. doi: 10.1155/2014/272376.
［37］	Carswell F, Kerr MM, Hutchison JH. Congenital goitre and hypothyroidism produced by maternal ingestion of iodides［J］. Lancet, 1970,1（7659）:1241⁃1243. doi: 10.1016/s0140⁃6736（70） 91736⁃8.
［38］	Kyriakidis I, Tragiannidis A, Munchen S, et al. Clinical hepatotoxicity associated with antifungal agents［J］. Expert Opin Drug Saf, 2017,16（2）:149⁃165. doi: 10.1080/14740338.2017. 1270264.
［39］	Khoza S, Moyo I, Ncube D. Comparative hepatotoxicity of fluconazole, ketoconazole, itraconazole, terbinafine, and griseofulvin in rats［J］. J Toxicol, 2017,2017:6746989. doi: 10.1155/2017/6746989.
［40］	Chen SC, Slavin MA, Sorrell TC. Echinocandin antifungal drugs in fungal infections: a comparison ［published correction appears in Drugs. 2011 Jan 22;71（2）:253］［J］. Drugs, 2011,71（1）:11⁃41. doi:10.2165/11585270⁃000000000⁃00000
［41］	Spernovasilis N, Kofteridis DP. Pre⁃existing liver disease and toxicity of antifungals［J］. J Fungi （Basel）, 2018,4（4）. doi: 10.3390/jof4040133.

[1]	Li Yuanjun, Han Yuyang, Zhang Huanzhen, Wang Hui, Shen Nan, Zhang Xinglian. Dupilumab in the treatment of 12 children with chronic spontaneous urticaria: a retrospective analysis [J]. Chinese Journal of Dermatology, 2024, 0(4): 20230439-e20230439.
[2]	Wang Shan, Wang Xingyu, Shu Hong, Zhang Bin, Shi Hang, Yang Huan, Qian Qiufang, Ma Hongyan, Liang Yuan, Zhao Mutong, Shen Chunping, Jiao Lei, Tian Jing, Wang Yang, Gu Ying, Sun Jing, Liu Ying, Li Ping, Wang Hua, Ma Lin. Efficacy of crisaborole ointment in clinical symptom relief in the early stage of childhood atopic dermatitis and in symptom improvement in the remission stage: a multicenter clinical study [J]. Chinese Journal of Dermatology, 2023, 56(9): 815-821.
[3]	Liu Yuanxiang, Liang Yuan, Zhao Xinrong, Sun Yujuan, Ma Lin, Xu Zigang. Janus kinase inhibitors for the treatment of five children with severe alopecia areata [J]. Chinese Journal of Dermatology, 2023, 56(9): 849-852.
[4]	Shen Chunping, Li Ping, Luo Xiaoyan, Liang Yuan, Liu Ying, Zhao Mutong, Wang Shan, Tian Jing, Jiao Lei, Wang Yang, Luo Zhen, Yu Shijuan, Fang Xiao, Wang Hua, Ma Lin . Efficacy of daily use of a test emollient combined with topical glucocorticoids applied at the weekend for delaying the recurrence of atopic dermatitis in children during the maintenance period: a randomized, blank-controlled, multicenter clinical study [J]. Chinese Journal of Dermatology, 2023, 56(8): 756-762.
[5]	Yuan Xingang, Ni Sili, Zhang Jian, Luo Xiaoyan, Wang Hua. Improving diagnosis and treatment of melanocytic nevi in children: an urgent need [J]. Chinese Journal of Dermatology, 2023, 56(8): 782-786.
[6]	Sun Linbo, Xu Jiaosheng. Curry-Jones syndrome: the first case reported in China [J]. Chinese Journal of Dermatology, 2023, 56(7): 626-629.
[7]	Guo Yanyang, Hai Luming, Zhu Zhenlai, Yan Dong, Zhu Guannan, Wang Gang, Fu Meng. Analysis of pathogenic fungi causing tinea capitis: a single-center retrospective study [J]. Chinese Journal of Dermatology, 2023, 56(6): 531-533.
[8]	Zhou Yabin, Xiao Yuanyuan, Chao Jinjing, Ma Lin. Comparison of oral terbinafine versus itraconazole in the treatment of tinea capitis in children [J]. Chinese Journal of Dermatology, 2023, 56(5): 438-440.
[9]	Ren Faliang, Wang Hua, Xiao Yizhu. Clinical characteristics of 57 cases of clear cell papulosis [J]. Chinese Journal of Dermatology, 2023, 56(4): 309-312.
[10]	Sun Peiwen, Wang Le, Wang Hongsheng, Yan Liangbin, Yu Meiwen. Epidemiological characteristics of leprosy in China from 2016 to 2020 [J]. Chinese Journal of Dermatology, 2023, 56(3): 204-209.
[11]	Tian Jing, Liang Yuan, Ma Lin. Dupilumab in the treatment of childhood atopic dermatitis [J]. Chinese Journal of Dermatology, 2023, 0(2): 20210730-e20210730.
[12]	Wang Zhaoyang, Xiang Xin, Chen Yunliu, Miao Chaoyang, Zhao Xinrong, Zhang Zhenhua, Liu Yuanxiang, Ma Lin, Xu Zigang. Comparison of efficacy and safety of biologics versus methotrexate in the treatment of severe pediatric plaque psoriasis [J]. Chinese Journal of Dermatology, 2023, 56(2): 112-117.
[13]	Jia Yuanyuan, Mao Qiuyu, Yang Jingyi, Min Wei. Efficacy of dupilumab in the treatment of moderate and severe atopic dermatitis in the elderly: a clinical observation [J]. Chinese Journal of Dermatology, 2023, 56(2): 125-129.
[14]	Chinese Society of Dermatology, Chinese Association of Rehabilitation Dermatology, Combination of Traditional and Western Medicine Dermatology, The Dermatology Branch of Chinese Medical Education Association. Expert consensus on diagnosis and treatment of senile herpes zoster [J]. Chinese Journal of Dermatology, 2023, 56(2): 97-104.
[15]	Deng Wei, Zhang Gaolei, Chen Jianyou, Zhang Sheng, Jiang Lixiao, Liu Xiaoyan, Su Wei. Skin manifestations of 61 children with coronavirus disease 19 [J]. Chinese Journal of Dermatology, 2023, 56(12): 1154-1157.

Application of antifungal agents in special populations

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［41］

Related Articles 15

Metrics

Comments

Recommended 10